Sino Medical Sciences Technology Inc. (SHA:688108)

SHA:688108 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	357.7	291.67	188.64	203.42	287.76	544.83
Cash & Short-Term Investments	357.7	291.67	188.64	203.42	287.76	544.83
Cash Growth	59.02%	54.62%	-7.27%	-29.31%	-47.18%	-15.73%
Accounts Receivable	13.63	7.47	8.94	20.28	12	66.67
Other Receivables	7.18	11.42	0.49	0.53	0.86	0.7
Receivables	20.81	18.9	9.43	20.82	12.86	67.38
Inventory	102.77	89.51	118.22	98.13	84.88	64.75
Prepaid Expenses	-	0	0.01	2.6	-	-
Other Current Assets	2.7	3.31	27.88	29.94	45.3	46.48
Total Current Assets	483.97	403.39	344.18	354.9	430.8	723.43
Property, Plant & Equipment	117.45	135.79	165.95	176.77	172.58	139.16
Long-Term Investments	-	-	14	18.95	33.65	5
Goodwill	46.22	46.22	-	-	-	2.58
Other Intangible Assets	179.9	189.31	53.4	52.87	73.92	82.07
Long-Term Deferred Tax Assets	95.2	111.88	105.33	91.78	44.17	5.86
Long-Term Deferred Charges	415.73	413.88	375.91	369.2	333.07	253.06
Other Long-Term Assets	0.34	0.08	127.05	3.14	14.89	6.34
Total Assets	1,339	1,301	1,186	1,068	1,103	1,217
Accounts Payable	39.17	13.94	20.12	13.41	8.57	20.07
Accrued Expenses	24.01	70.64	57.65	62.19	55.18	63.38
Short-Term Debt	91.47	53.05	53.55	35.54	5.01	-
Current Portion of Long-Term Debt	15.8	4.56	0.76	-	-	-
Current Portion of Leases	-	11.51	14.96	10.95	11.78	-
Current Income Taxes Payable	5.09	0.02	-	-	-	0.13
Current Unearned Revenue	1.07	1.87	1.12	0.79	0.41	0.79
Other Current Liabilities	45.99	36.43	3.12	9.3	11.6	7.8
Total Current Liabilities	222.61	192.02	151.27	132.18	92.56	92.18
Long-Term Debt	123.25	137	105.3	-	-	-
Long-Term Leases	17.52	18.99	24.92	11.83	27.49	-
Long-Term Unearned Revenue	6.61	13.32	21	2	1.94	2.48
Long-Term Deferred Tax Liabilities	37	40.89	20.22	22.72	21.47	17.53
Other Long-Term Liabilities	-	-	1.46	11.4	14.47	27.44
Total Liabilities	407	402.22	324.17	180.13	157.92	139.63
Common Stock	416.05	413.46	410	410	410	410
Additional Paid-In Capital	661.9	651.98	608.92	596.87	527.37	545.23
Retained Earnings	-178.32	-199.44	-200.94	-161.31	-8.44	122.33
Comprehensive Income & Other	1.12	0.89	1.97	1.52	-1.09	0.31
Total Common Equity	900.75	866.89	819.96	847.08	927.84	1,078
Minority Interest	31.06	31.45	41.69	40.4	17.33	-
Shareholders' Equity	931.81	898.34	861.65	887.48	945.16	1,078
Total Liabilities & Equity	1,339	1,301	1,186	1,068	1,103	1,217
Total Debt	248.05	225.11	199.49	58.31	44.27	-
Net Cash (Debt)	109.65	66.56	-10.85	145.11	243.48	544.83
Net Cash Growth	-	-	-	-40.40%	-55.31%	-15.73%
Net Cash Per Share	0.26	0.18	-0.03	0.36	0.60	1.33
Filing Date Shares Outstanding	416.05	413.46	410	410	410	410
Total Common Shares Outstanding	416.05	413.46	410	410	410	410
Working Capital	261.36	211.37	192.9	222.72	338.24	631.26
Book Value Per Share	2.17	2.10	2.00	2.07	2.26	2.63
Tangible Book Value	674.64	631.36	766.55	794.21	853.92	993.22
Tangible Book Value Per Share	1.62	1.53	1.87	1.94	2.08	2.42
Machinery	-	265.54	286	278.74	226.45	179.29
Construction In Progress	-	1.17	1.55	6.66	11.92	40.94

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.